Xcout IntelSign inSubscribe

Novartis

NVSPharmaceuticalsBasel, Switzerland

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Subscribe to see Novartis’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

Novartis at a glance

Novartis is a pharmaceuticals company headquartered in Basel, Switzerland, founded in 1996. It is publicly listed (NVS) with a market capitalisation of $285.8B. Xcout tracks 32 named people at Novartis, including Vasant Narasimhan (Chief Executive Officer). Xcout recorded 844 job postings from Novartis in the last 90 days, naming tools such as SAP, Salesforce, Alteryx.

Industry
Pharmaceuticals
Headquarters
Basel, Switzerland
Market cap
$285.8B
Employees
75,267
Ticker
NVS
Founded
1996
Job postings recorded (90 days)
844
Xcout AI Rank
40/100
Xcout Green Rank
5/100

Novartis leadership

  • Vasant NarasimhanChief Executive Officer
  • Victor BultoPresident of US
  • Patrick HorberPresident of International
  • Steffen LangPresident of Operations
  • Mukul MehtaChief Financial Officer
  • Karen L. HaleChief Legal & Compliance Officer

26 more named people on record for Novartis, with roles, board committees and tenure — see the full roster →

Hiring at Novartis

Xcout recorded 844 job postings from Novartis in the last 90 days, from a hiring record Xcout has kept since June 2026.

Tools named in Novartis's job postings

SAPSalesforceAlteryxJiraMicrosoft CopilotPower BIAnthropicGitHubOpenAI APIServiceNow

The weekly hiring trend, the roles and locations behind it — see Novartis's hiring signals →

Recent Novartis news

7 corporate events on record, with sources — see the full timeline →

Novartis competitors

A few of Novartis's closest competitors — see the full list of competitors and alternatives →

Get Novartis's news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Something wrong or missing about Novartis? Suggest a correction

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

Novartis — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on Novartis in Xcout Intel

  • 32 named people with titles, LinkedIn and board committees
  • Weekly hiring history and the mix of roles behind it
  • 7 corporate events with sources — deals, leadership changes, layoffs
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →